Laxative Formula By Integrative Therapeutics Overview & Drug Interactions

Check For Interactions With Laxative Formula

Supplement: Laxative Formula by Integrative Therapeutics

Laxative Formula Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Laxative Formula by Integrative Therapeutics

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
2 Tablet(s)
Maximum serving Sizes:
3 Tablet(s)
Servings per container 11
UPC/BARCODE 871791002319

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Calories
10 Calorie(s)
Header
Total Carbohydrates
1 Gram(s)
Carbohydrate 1%
Dietary Fiber
1 Gram(s)
Fiber (unspecified) 4%
Magnesium Hydroxide
2.6 Gram(s)
Magnesium hydroxide --
Proprietary Mucilage Blend
650 mg
Proprietary Blend (Herb/Botanical) --
Marshmallow (Althaea officinalis) root extract
0 NP
Marshmallow
Slippery Elm
0 NP
Slippery Elm
Fenugreek (Trigonella foenum-graecum) seed extract
0 NP
Fenugreek
Burdock (Arctium lappa) root extract
300 mg
Burdock --
Proprietary Soothing Blend:
150 mg
Proprietary Blend (Herb/Botanical) --
Fennel
0 NP
Fennel
Ginger (Zingiber officinale) rhizome extract
0 NP
Ginger
Peppermint
0 NP
Peppermint
Red Clover (Trifolium pratense) blossom extract
100 mg
Red Clover --

Other Ingredients:
Cellulose
Stearic Acid
modified Cellulose Gum
Modified Cellulose
Magnesium Stearate
Glycerin
Silicon Dioxide
Soy Lecithin


Label Statments:


Precautions
- Warnings: Consult a healthcare professional if a sudden change in bowel habits occurs and persists for two weeks. Rectal bleeding or failure to have a bowel movement after use of a laxative may indicate a serious condition; discontinue use and consult a healthcare professional.
- Do not use if pregnant or nursing.
- Do not take more than three tablets in a 24-hour period or use the maximum dosage for more than two weeks.
- If taking prescription drugs or if you have gallstones or bile duct obstruction, consult your healthcare professional prior to use.
- Reduce dosage if you experience abdominal discomfort or diarrhea. If discomfort persists, discontinue use.
- Unless directed by a healthcare professional, do not use laxative products when abdominal pain, nausea, or vomiting is present, or if you have kidney disease.
General Statements
- For more information, please visit integrativepro.com
- Laxative Formula
Formulation
- Contains no sugar, salt, yeast, wheat, gluten, dairy products, artificial colors, flavors, preservatives, or ingredients of animal origin.
General
- LZ78967.A02 BLK896A
FDA Disclaimer Statement
- This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
FDA Statement of Identity
- Dietary Supplement
Suggested/Recommended/Usage/Directions
- Recommendation: Day 1 through day 7: Take 3 tablets at bedtime with 8 ounces of water. Day 8 through day 14: Take 2 tablets at bedtime with 8 ounces of water, or as recommended by your healthcare professional.

Brand Information

See all products by this brand

Manufacturer
Name Integrative Therapeutics, LLC
City Green Bay
State WI
Country USA
ZipCode 54311
Phone Number 800.931.1709
Web Address integrativepro.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.